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Abstract
Background: There is growing evidence that many diseases develop, progress, and respond to therapy differently
in men and women. This variability may manifest as a result of sex-specific structures in gene regulatory networks
that influence how those networks operate. However, there are few methods to identify and characterize differences in
network structure, slowing progress in understanding mechanisms driving sexual dimorphism.
Results: Here we apply an integrative network inference method, PANDA (Passing Attributes between Networks for
Data Assimilation), to model sex-specific networks in blood and sputum samples from subjects with Chronic Obstructive
Pulmonary Disease (COPD). We used a jack-knifing approach to build an ensemble of likely networks for each sex. By
adapting statistical methods to compare these network en s e m b l e s ,w ew e r ea b l et oi d e n t i f ys t r o n gd i f f e r e n t i a l -
targeting patterns associated with functionally-related sets of genes, including those involved in mitochondrial
function and energy metabolism. Network analysis also identified several potential sex- and disease-specific
transcriptional regulators of these pathways.
Conclusions: Network analysis yielded insight into potential mechanisms driving sexual dimorphism in COPD that
were not evident from gene expression analysis alone. We believe our ensemble approach to network analysis
provides a principled way to capture sex-specific regulatory relationships and could be applied to identify differences
in gene regulatory patterns in a wide variety of diseases and contexts.
Keywords: Network modeling, Gene regulation, Regulatory networks, Sexual-dimorphism, Chronic Obstructive Lung
Disease
Background
Chronic respiratory diseases, including Chronic Obstruct-
ive Pulmonary Disease (COPD), are among the most likely
causes of death in the United States; COPD ranks third
only after heart disease and all forms of cancer combined
[1]. In the past COPD was thought to primarily affect
males, but in recent years the number of females with
COPD has greatly increased, and currently more women
die of COPD than men [2]. Some of the changing epi-
demiology is likely due to an increase in female
cigarette use during the 1960s. However, current re-
search also suggests biological causes for the apparent
sexual-dimorphism in the disease, with women having
a higher susceptibility [3-5], an overall more severe
COPD course even with the same level of tobacco ex-
posure [6], and an increase in severe symptoms at a
younger age [2,7].
Investigating sex differences in disease is a critical area
of investigation [8,9] and a wide number of diseases are
known to effect men and women differently [10]. It has
been noted that many sexually dimorphic features are
likely not primarily due to genetic variation [11]. On the
other hand, network-modeling of transcriptomes in model
organisms has demonstrated sexually dimorphic higher-
order gene interactions [12]. Consequently, systems-based
approaches have great potential for exploring sex-
differences in human traits [13,14]. In this study we le-
verage gene expression data from subjects with COPD
to build sex-specific networks and investigate whether
alterations in gene regulation might contribute to
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here are not limited to analysis of lung disease but are
generalizable to other diseases that demonstrate sexu-
ally dimorphic characteristics.
Gene regulation involves the concerted activity of
many distinct but non-independent regulatory mecha-
nisms [12,14]. While no single experimental assay can
fully capture the complexity of a given biological system,
each provides information concerning a particular fea-
ture that influences, or results from, the state of a cell.
Because of the complexity of gene regulatory processes,
there is increased interest in modeling approaches capable
of integrating multiple sources of regulatory information
[15-19], and evidence suggests that these methods per-
form much better than those using individual data types
in isolation [20].
Along these lines, we developed PANDA (Passing At-
tributes between Networks for Data Assimilation) [21], a
“message passing” network inference method that inte-
grates multiple types of genomic data. PANDA models
information flow through networks under the assump-
tion that both “transmitters” and “receivers” play active
roles in modulating regulatory processes. In PANDA’s
model of gene regulatory control, transcription factors
are the transmitters and the receivers are their target
genes. A set of initial connections linking transcription
factors to potential downstream targets is inferred by
mapping transcription factor binding sites (TFBS) to the
genome. Gene expression profiles provide information
on shared activation states for elements in the network
and protein-protein interaction data provide information
on co-regulatory processes. PANDA starts with initial
networks and then uses the various data to iteratively
update the network structures to more accurately fit the
available information, until the process converges on a
consensus regulatory network.
In applying PANDA, we construct phenotype-specific
models and then look for variation in TF-target interac-
tions (“edges”) to explore regulatory differences. One
surprising result of applying PANDA in such a compara-
tive analysis is that we are able to observe meaningful
changes in regulatory patterns even for genes that are
not differentially expressed [22].
The comparative analysis of phenotype-specific net-
works enabled by PANDA makes it particularly useful
for studying sexual dimorphism in health and disease,
where the absolute levels of gene expression in disease
may be similar in male and female tissues but in which
different regulatory processes may be active [14], includ-
ing differences in transcription factor regulation in the
presence of sex hormones [23,24]. If this is the case,
identifying sexually dimorphic network variability and as-
sociating these network characteristics with specific dis-
ease processes can lead not only to a better understanding
of the disease, but also to therapies optimized for men and
women.
In this study we begin by analyzing blood and sputum
gene expression data from subjects with COPD. We
then explore whether gene regulatory networks, esti-
mated using these data, contain sex-specific regulatory
patterns. To do this we use PANDA to model “ensem-
bles” of sex-specific regulatory networks in COPD and
use these network ensembles to identify differences in
network topologies that are associated with biological
functions in a sex-specific manner. As opposed to ana-
lyzing or contrasting the properties of single networks,
this ensemble approach to network analysis allows for
the statistical quantification of network features. In this
application, we demonstrate how Gene Set Enrichment
Analysis (GSEA), which was originally designed to quan-
tify the association of gene sets with differential expres-
sion changes, can be used to estimate the association of
gene sets with alterations in network features in light of
this ensemble approach. However, more generally, our
ensemble approach to network modeling allows for the
principled investigation of differences in network prop-
erties using statistical tools developed for genomic and
other high-dimensional data.
Results and discussion
Genes and gene sets are not strongly differentially-
expressed between males and females with COPD in
either blood or sputum
We obtained and analyzed gene expression data in spu-
tum and blood samples from 132 subjects (44 females and
88 males) with COPD enrolled in the ECLIPSE study [25].
Affymetrix CEL files were downloaded and normalized
using RMA [26], with probe-sets mapped to Entrez-gene
IDs using a custom CDF [27]. An initial quality control of
this data was performed by running a principal compo-
nent analysis on the expression values for the 24 probe-
sets located on the Y chromosome. A plot of the first
versus the second principal component (Additional file 1:
Figure S1A) indicates that although most samples cluster
according to the sex ascribed in the phenotype data, there
are six samples which do not cluster as expected. To
minimize potential noise due to poor quality data or sex
misclassification, we eliminated these six subjects from
further consideration, leaving 42 female and 84 male
COPD subjects with both sputum and blood gene expres-
sion data. A principal component analysis plot for these
remaining samples, generated using expression informa-
tion for genes located on the Y chromosome, is shown in
Figure 1A; age, COPD Global Initiative for Chronic Ob-
structive Lung Disease (GOLD) stage based on spirometry
and pack-years of cigarette smoking for the corresponding
subjects are shown in Figure 1B. We compared the age,
COPD GOLD stage and pack-years of cigarette smoking
Glass et al. BMC Systems Biology 2014, 8:118 Page 2 of 17
http://www.biomedcentral.com/1752-0509/8/118between men and women and observe significant differ-
ences in age and pack-years but no significant difference
in disease stage. This is consistent with previous observa-
tions that women often get similarly severe COPD at a
younger age and with less smoke exposure [2,6,7] and
highlights the importance of understanding the biologic
features mediating sexual dimorphism in COPD. All sub-
jects included in this analysis are former smokers.
For the remaining 126 subjects, a genome-wide differen-
tial expression analysis including the sex chromosome
genes serves as a strong positive control on the expression
data as the results identify many expected sex-related dif-
ferences (Additional files 1: Figure S2 and Additional
file 1: Tables S1–S2).We next excluded genes on the
sex chromosomes and tested if autosomal genes were
strongly differentially-expressed between males and fe-
males in either the sputum or blood samples, using an un-
paired two-sample t-test. Using the sputum samples, no
genes are significantly differentially expressed between
males and females at an FDR less than 0.1. Only eight
autosomal genes (listed in Figure 1C) are significantly
differentially-expressed in blood between female and male
COPD subjects at an FDR threshold of 0.1, suggesting that
the removal of sex chromosome genes largely mitigates
the sex-specific gene expression signal. Consequently, sub-
sequent analyses exclude genes on the sex chromosomes.
Although very few autosomal genes are significantly
differentially-expressed when comparing samples from
males and females, it is still possible that groups of inter-
acting genes, representing particular biological functions,
Figure 1 Comparison of males and females with COPD using a standard differential-expression analysis approach. (A) A PCA analysis on
expression data using genes located on the Y chromosome. Males and females cluster into two groups. (B) Covariate information for the 42 female
and 84 male subjects included in the analysis. The statistical difference between sexes for age and pack-years was calculated using an unpaired two-
sample t-test and the statistical difference between the sexes for GOLD stage was calculated by applying a chi-squared test to a two by three (sex by
stage) contingency table. (C) The top most differentially-expressed genes based on a using an unpaired two-tailed t-test (after specifically excluding
genes those on the sex chromosomes). Genes with higher average expression in female are colored pink and those with higher average expression in
male are colored blue. (D) The results of a GSEA analysis looking for GO category differential-expression between males and females. The five most
differentially-expressed GO categories in males and females in either sputum or blood are shown. Deeper shades of pink are used to denote greater
significance in female while deeper shades of blue indicate greater significance in males. The scale is based on the –log FDR significance for categories
enriched in females, resulting in positive values, and on the+log FDR significance for categories enriched in males, resulting in negative values. Note
that the color-range extends to an FDR significance of 10
−3 in each sex even though the most significant categories found in this analysis only reach
an FDR significance of around 10
−2. (E) GSEA “enrichment plots” for the two most significantly differentially-expressed GO categories according to the
GSEA analysis in males and females in either sputum or blood.
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specific manner. We evaluated this possibility by per-
forming Gene Set Enrichment Analysis (GSEA) [28]. We
downloaded the java implementation of GSEA (http://
www.broadinstitute.org/gsea/) and tested for the collect-
ive sex-specific differential expression for sets of genes
annotated to Gene Ontology (GO) functional categories.
GSEA uses a gene-by-sample table of expression values
and information concerning sample features (in this ana-
lysis, subject sex) to rank genes based on their differen-
tial expression. It then uses this ranking to test if sets of
genes (for example, those annotated to a particular GO
term) have consistent changes in expression patterns, in
our case, consistently higher expression levels in one sex
compared to the other.
Figure 1D shows the five most differentially-expressed
functional gene sets (hereafter, simply “functions” or “GO
terms”) in males and females for both sputum (top panel)
and blood (bottom panel). Several of the corresponding
GSEA enrichment plots are presented in Figure 1E. Al-
though the top functions are only marginally significant,
both the blood and sputum analysis includes several inter-
esting results. In sputum, the most differentially-expressed
functions reach an FDR significance in the range of 0.01
to 0.15 and include GO terms such as “sterol biosynthetic
process” and “steroid hydrolase activity”, which may play a
role in sexual dimorphism. The GO functions more highly
expressed in COPD blood samples in males compared to
females include “cell killing” and “phagocytosis”, processes
potentially related to COPD pathogenesis and severity
[29,30].
Jack-knifing can be used to robustly estimate and
compare regulatory networks
We also used a two-sample f-test to evaluate if the vari-
ance of any of the autosomal genes’ expression levels was
significantly difference between females and males. We
observe that in sputum samples over 1000 genes are
differentially-variable at an FDR less than 0.1. We include
these genes in Additional file 2. This observation, together
with the plausible functional enrichment results, led us to
next hypothesize that the differential targeting of bio-
logical functions may play a critical role in sexual di-
morphism in COPD. Specifically, it is possible that genes
are differentially co-expressed, even if their overall average
expression levels are not significantly different. If this dif-
ferential co-expression is taken as evidence of differential
co-regulation, as is done in PANDA, then potential tran-
scription factors that are differential-targeting these genes
can be identified (Additional file 1: Figure S3).
It has been suggested that regulatory relationships be-
tween transcription factors and genes likely have both sto-
chastic and deterministic components, and thus may be
better modeled by probability distributions as opposed to
simple Boolean relationships [31,32]. Furthermore, in this
application we recognized that differences in sample size
between males and females could potentially influence
predictions of regulatory network interactions. Motivated
by this, we used PANDA [21] to calculate ensembles of
networks based on jack-knifed sets of samples drawn
from our initial male and female subject populations
(Figure 2A).
Specially, As an input to PANDA, we constructed
transcription-factor target networks using position-
weight-matrices for 130 TFs recorded in the Jaspar
database [33], mapping these to the promoter regions, de-
fined as [−750,+250] base-pairs around the transcription
start site. We also include information regarding physical
protein-protein interactions between human transcription
factors [34]. To build ensembles of networks, we used a
“jack-knife” [35], randomly selecting ten samples without
replacement to create 400 gene expression data sets, 100
for each of four sample sets (blood-female, blood-male,
sputum-female, sputum-male). We then used PANDA to
infer networks for each expression data set. As a negative
control, we also created a version of the sputum expres-
sion data with a permutation of gene labels, and built sex-
specific ensembles of networks for this randomized data.
This jack-knifing approach ensures that the predicted
network edges are not strongly influenced by any one
subject, as each network in our ensembles represents
an estimate of the cellular regulatory network for a sub-
set of the relevant samples. It also helps us regularize
differences in sample size between the sexes as each of
the reconstructed networks contains information from
the same number of subjects. Further, our male and fe-
male ensembles each include one hundred networks,
giving us the power to quantify the statistical properties
of the estimated regulatory edges, something that would
have been difficult or impossible had we simply esti-
mated a single network for each sex and tissue-type
combination. Although the jack-knifing approach does
not allow us to directly model covariates (for example,
differences in COPD severity or smoking histories), it
helps mitigate their effect on the network predictions
by modeling a distribution of networks, which are, on
average, representative of the population, but whose
variance likely represents the contribution of other
factors.
We used an un-paired two-sample t-test to quantify
differences in the distributions of predicted edge-weights
between the sex-specific network ensembles. We also av-
eraged the predicted edge weight across the networks in
each ensemble, excluded edges with low average weights
(<0) and, for the remaining edges, determined the dif-
ference in these average edge weight values between
t h ee n s e m b l e s .F i g u r e2 B - Ds h o w sv o l c a n op l o t so ft h e
difference in the average of each edge’s weight between
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cance in the difference of edge weight distributions based
on the t-test. We immediately observe that edge differ-
ences in the “random” volcano plot are not nearly as
strong as those in the sputum and blood volcano plots;
however, there are some differences, including edges that
are “significantly” different according to the t-test. Conse-
quently in this following network edge analysis we use a
more stringent FDR cutoff than we did with the gene ex-
pression analysis.
We used a combination of the difference (absolute
value >0.25), significance based on the t-test (FDR <10
−5)
and average edge weight (>0) to select differentially-called
edges for each ensemble comparison. Female- and male-
specific edges are shown in pink and blue, respectively, in
Figures 2B-D. These criteria were chosen such that each
sex-specific subnetwork contains edges that are both likely
to be real (based on a positive edge weight) as well as dif-
ferent, both at an absolute and at a statistical level. The
cutoff values themselves were selected such that each
A
B
C
D
E
F
G
H
I
J
Figure 2 Using ensembles of networks to robustly identify sex-specific interactions and their associated genes. (A) A cartoon summary
of how we use PANDA to build ensembles of networks using a jack-knifing approach to resample the original expression data multiple types.
(B-D) Volcano plots of the difference in mean edge weight across two ensembles of networks compared to the p-value of the difference in the
edge weight distributions in the two ensembles. Comparisons include (B) female versus male sputum networks, (C) female versus male blood
networks, (D) female versus male “random” networks. Edges identified as “different” in each comparison are shown as either pink (female-specific)
or blue (male-specific). (E-G) Venn diagrams showing the overlap in genes targeted by the female-specific (pink) or male-specific (blue) edges.
Note that a gene can be targeted by both a male-specific and a female-specific edge, but by different upstream transcription factors. There is a
high level of overlap in the genes targeted by the identified sex-specific edges in both the sputum and blood networks. (H-J) A hypergeometric
probability was used to determine the significance of overlap in male-specific genes with genes annotated to GO categories, and female-specific
genes with genes annotated to GO categories. The top five categories enriched in the males and females for each comparison are shown.
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possible edges, which may be close to an expected net-
work density. We applied these same cutoffs to the “ran-
dom” volcano in order to quantify the level of false
positives in the differential subnetwork edge calls. Al-
though there are likely false-positive edges in our identi-
fied subnetworks, for the selected cut-offs there are
approximately 2.4 and 9.4 times more differentially-called
edges in the sputum and blood volcanos compared to the
random volcano, respectively. We note that this
randomization control also illustrates that statistical differ-
ences calculated by contrasting various network properties
should be viewed primarily as a rank-ordering as opposed
to a true significance level.
We determined the genes targeted by these sex-
specific edges and present the results as Venn diagrams
(Figure 2E-G). Many genes (5389 in sputum and 8133 in
blood) are targeted in both male and female subnetworks,
although the network models indicate the regulation is
governed by different transcription factors. This may par-
tially explain why we previously observed only minimal
differential gene expression patterns between the sexes;
our network results suggest that although genes may be
similarly expressed in both sexes, this is mediated by a dis-
tinct set of transcriptional regulators.
To assess whether the genes targeted in only one sex-
specific subnetwork and not the other might be associ-
ated with specific biological functions, we used Fisher’s
exact test to evaluate the enrichment of GO categories
in these genes and observe some functional enrichment
(Figure 2H-J). The signal appears to be strongest for the
genes uniquely targeted in a sex-specific manner in the
sputum-derived networks (Figure 2H); the sputum sam-
ples may be biologically “closer” to the disease as a lung
source sample and may represent cellular process most
likely to be associated with COPD.
Network ensembles uncover differential-targeting patterns
in men and women with COPD
We recognize that there are significant limitations to
studying functional enrichment in a context that relies
upon somewhat arbitrary thresholds in order to define
differential subnetworks (Figure 2B-J). Firstly, this type
of approach can be sensitive to the cutoffs used, opening
the opportunity for potentially biased results when not
used with caution. Additionally, selecting genes based
on whether they are or are not targeted in a pair of net-
works ignores any relative l e v e lo fd i f f e r e n t i a lt a r g e t i n g .
Specifically, we observe a high level of overlap in target
genes when comparing male and female subnetworks (see
Figure 2E-G); however, there are multiple instances when a
gene is targeted by many transcription factors in one sub-
network but by a much smaller number, or even a single
TF in the other. Although we excluded these commonly
targeted genes in the analysis shown in Figure 2E-J, one
could imagine they might play a significant role in sex-
specific differences in COPD.
Motivated to overcome these limitations, we next used
the ensembles of networks generated by PANDA in a
manner analogous to how we used the expression data
to evaluate differential-enrichment of GO functions be-
tween the sexes. We previously observed that some sets
of functionally-related genes are weakly differentially-
expressed (Figure 1D); here we wish to address a similar,
but distinctly different question within the network
context. Namely, are sets of functionally-related genes
differentially-targeted?I no t h e rw o r d s ,d oas e to f
functionally-related genes tend to have an increase (or
decrease) in regulatory targeting in one sex-specific
regulatory network context compared to another?
In this analysis, instead of sets of expression samples
associated with disease state and sex, we have sets of
regulatory networks. Specifically, we have one hundred
corresponding representative networks for each set of
expression samples, and therefore one hundred pre-
dicted scores for each edge in those networks. Figure 3A
shows a heat map of those scores for the male and fe-
male sputum networks. Some edges have consistently
higher predicted edge weights in the male networks
while others have consistently higher predicted edge
weights in the female networks. We would like to relate
these differences in network structure to differences in
the regulation of biological functions.
To begin to address this question, within each of our
sex-specific PANDA predicted networks, we assigned
every gene a score based on its “in-degree”, which is de-
fined as the sum of the weights of all edges pointing to
that gene. Figure 3B shows the in-degree values side-by-
side for the male and female sputum networks. We
sorted genes in this figure based on the statistical differ-
ence in the in-degree values between the two network
ensembles, as measured by an unpaired two-sample t-
test. As with the edges, we observe that some genes are
consistently much more highly targeted in the male net-
works, while others are consistently much more highly
targeted in the female networks. The twenty-five most
differentially-targeted genes, based on the t-test compari-
son, are shown in Figure 3C. As a control for this analysis
we also reconstructed one hundred networks built after
permuting the sex-labels of the subjects (Additional file 1:
Figure S4A). We observe that the differential-targeting ob-
served for these genes is much greater than expected by
chance.
Our calculated in-degree values give an indication of
how heavily a gene is targeted in a given network. Edge-
weights predicted by PANDA correspond to how likely a
given regulatory interaction is to exist and edges that
represent either activating or repressing interactions can
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relatively higher degrees are not necessarily “more acti-
vated,” they may in fact be repressed (if they are highly tar-
geted by more repressors than activators), or neither (if
they are equally targeted by both activators and repres-
sors). Therefore, a change in a gene’s degree between two
sets of networks is not necessarily related to either an in-
crease or decrease in its expression level, but instead sug-
gests changes in its regulatory control. Consistent with
this framework, even the most strongly differentially-
targeted genes do not appear to be strongly differentially-
expressed (Figure 3C). We therefore suggest that these
differences in gene targeting likely represent a sexually-
dimorphic disease-related re-wiring of the cellular net-
work and that understanding the biological implications
of these structural changes may provide insight into the
mechanisms driving disease morphology and lead to sug-
gestions for sex-specific therapies.
AB C
DE
Figure 3 Visualization of edge weight and the in- and out-degree of genes and TFs in ensembles of sputum networks. (A) Edge weights
for every possible transcription factor to gene interaction, where each row represents an edge, and each column represents one of the networks
produced in the jack-knifing approach. Rows are ordered based on the t-statistic comparing the edge weight values and each row is Z-score
normalized for visualization purposes only. (B) The in-degree, defined as the sum of all incoming edge weights, for each gene in the PANDA
network reconstruction. Genes (rows) are ordered based on the t-statistic comparing the gene in-degree distributions in the two ensembles
of networks (columns). Again, rows are Z-score normalized only for visualization purposes. (C) The twenty-five most differentially-targeted
genes, identified as having the most significant difference in in-degree in the male compared to the female ensemble of networks. Both the
significance of the differential-targeting and the level of differential-expression is shown. (D) The out-degree, defined as the sum of all outgoing edges,
for each transcription factor in the reconstructed networks. Rows represent transcription factors and are again ordered based on the t-statistic
comparing the distribution of in-degree values of the transcription factor in the two ensembles of networks. (E) The ten most differentially-
targeting transcription factors, and their level of differential-expression. The majority of the differentially-targeted genes and differential-targeting
transcription factors are not differentially-expressed.
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networks, or the sum of the weights of all edges pointing
from a TF, and show the results in Figure 3D-E. As be-
fore, we observe strong sex-specific differences in target-
ing patterns, even though the TFs themselves are not
differentially-expressed. These results suggest that differ-
ences in regulatory patterns in the absence of strong dif-
ferential expression exist around the regulating TFs as
well as the regulated genes. Thus the sex differences we
observe appear to be strongest at the level of the net-
work “edge” and not necessarily in the individual “node”
(gene and TF) states.
Biological functions are strongly associated with sexually-
dimorphic targeting in COPD subjects
Our analysis suggests that although there is little differ-
ence in gene expression levels between males and females
with COPD in either blood or sputum, there are likely dif-
ferent regulatory mechanisms associated with and poten-
tially mediating the disease state. If this is true, one would
expect that alterations in network structure should be
concentrated around genes representing particular func-
tional classes representing changes in the mechanisms of
activation, rather than downstream changes in gene ex-
pression. Therefore, next we sought to identify sexually di-
morphic differentially-targeted functions. We created
“gene-by-network” tables for each ensemble of networks,
where the values are the in-degrees of the genes (the level
of targeting identified by PANDA) in each of our pre-
dicted networks. We then ran GSEA using these in-degree
values instead of expression to evaluate if functionally-
related sets of genes gain or lose targeting.
Running GSEA on differential gene-degree leads to
some striking results (Figure 4A). First, despite the lack of
strong differential-expression noted previously, directly
comparing male versus female networks using this enrich-
ment method reveals strong patterns of differential-target-
ing, with many functions that have significantly (FDR<
0.01) more targeting in the female compared to the male
networks (Figure 4A). Differential-targeting of these func-
tional categories is absent in networks reconstructed after
permuting the sex-labels (Additional file 1: Figure S4B).
Furthermore, the results are highly consistent when com-
paring female and male networks built using either the
sputum or blood samples (although there is overall greater
enrichment for differential-targeting of functions in the
sputum). In contrast, repeating the analysis using net-
works constructed from “random” expression data shows
no strong differential-targeting patterns.
Closer inspection of the differentially-targeted func-
tions shows many to be highly-related based on their
biological role and gene content. Figure 4B shows the
ten most differentially-targeted functions in females and
males in sputum. A closer inspection of the expression
levels of the genes annotated to these top functional cat-
egories shows that they appear to be associated with dis-
ease stage (Additional file 1: Figure S5), supporting their
relevance to COPD. The pathways most significantly tar-
geted in men are related to type I interferon, which has
previously been implicated in the sexual dimorphism in
response to viral infections (drivers of COPD exacerba-
tions) [36,37] and in autoimmune diseases [38]. They are
also consistent with previous observations that immune
functions are enriched in male COPD-associated genes
AB
Figure 4 Sexually-dimorphic targeting of biological functions in Sputum and Blood networks. (A) All GO categories significantly
differentially-targeted (FDR<0.01) using a GSEA-type approach to compare gene targeting in male and female networks derived from either sputum
or blood expression data. Many functional categories have genes that appear to be much more highly targeted in the female networks compared to
the male networks. There is a high level of agreement between the differential-targeted GO categories in both the sputum and blood networks, but
the enrichment disappears in the “random” networks. (B) The ten most differentially-targeted pathways enriched in the female and the male sputum
networks.
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all related in some way to mitochondrial function, which
has previously been implicated in the modulation and
development of lung disease [40,41]. Cigarette smoking
has also been shown to change mitochondrial morph-
ology [42] and abnormal mitochondrial function is de-
scribed in patients with COPD [43,44].
Because of its maternal inheritance [45,46], the mito-
chondria has long been associated with sex-differences.
Sex hormones play an important role in controlling
mitochondrial biogenesis and activities [47-50]. In neur-
onal cells ER-beta is localized in the mitochondria and
mediates mitochondrial vulnerability to oxidative dam-
age [51,52]; it also impairs mitochondrial oxidative me-
tabolism in mesothelioma [53]. Interestingly, estrogen
receptors are reduced in the mitochondria of epithelial
cells from asthmatic lungs [54]. In addition, multiple
peroxisome proliferator-activated receptors (PPARs), a
class of nuclear hormone receptor proteins, have lower ex-
pression levels in COPD patients. This activity corresponds
to lower expression levels of the PPAR-γ co-activator
PGC-1α [55], a key regulator of energy metabolism [56]
and an inducer of mitochondria biogenesis [57]. Thus
differential-targeting of mitochondrial functions is con-
sistent both with known biology concerning sexual-
dimorphism and COPD.
We have performed two analyses to confirm that the
strong differential-targeting of biological functions we
observe in these networks is not a consequence of our
specific approach. First, we repeated the ensemble net-
work reconstruction on the sputum expression data, but
modified our sampling technique to match covariates
between each selected set of ten female and ten male
samples; the conclusions of this covariate-matched ana-
lysis are nearly identical to what we observe with the
random sampling (Additional file 1: Figure S6). Secondly,
we ran (1) one hundred GSEA differential-expression ana-
lyses, one for each set of ten versus ten expression sam-
ples, and (2) one hundred GSEA differential-targeting
analyses, one for each female versus male network recon-
structed from these samples. Across these analyses we
again observe consistently strong differential-targeting of
many biological functions (Additional file 1: Figure S7).
Transcription factors mediate differential-targeting patterns
in COPD
To gain a better appreciation for the network-level pat-
terns that might be driving the identified functional al-
terations, we constructed a gene-by-TF matrix of the
t-statistic values associated with the differences in edge
weights predicted for the female compared to the male
sputum networks and performed a complete-linkage
hierarchical clustering using a Pearson correlation coef-
ficient distance (Figure 5A). The resulting heatmap, where
the rows are genes and the columns are transcription fac-
tors, shows clear patterns involving sets of transcription
factors differentially-targeting sets of genes in the female
and male networks. Given these results, we next sought to
identify if particular transcription factors might be mediat-
ing the differential-targeting of biological functions be-
tween men and women.
For each jack-knife iteration PANDA calculates an edge
weight for every possible transcription factor to gene
interaction representing the likelihood that the TF regu-
lates that target gene. We used this information to design
TF-specific gene-by-network tables. We ran GSEA on
these TF-specific tables to evaluate if any functions are
more strongly targeted by an individual TF in one of our
ensembles of networks compared to the other. The results
of the female versus male comparison in both sputum and
blood are shown in Figure 5B-C, with the transcription
factors shown in the same order as in the hierarchical
clustering and each row representing a biological function
found to be enriched (FDR<0.01) when contrasting at
least one set of male or female TF-specific edges. We find
more than 1000 GO functions differentially-targeted be-
tween the sexes by at least one transcription factor in spu-
tum, and almost 900 in blood. As with the gene in-degree
analysis we once again see much stronger differential-
targeting of functions in the sputum network comparison
relative to the blood network comparison.
Disease-specific regulators of sexually-dimorphic functional
targeting
In order to better interpret this information, we focused
on our previously-identified ten most differentially tar-
geted functions (see Figure 4B) and present the TF-
specific GSEA results in Figure 6A. We see overall
consistency between the blood and sputum sexually-
dimorphic targeting of these functions by individual
transcription factors. However, a handful of transcrip-
tion factors appear to have opposite patterns in the
sputum and the blood networks.
One limitation of directly comparing data from men
and women with COPD is that without healthy controls
it is unclear whether the systemic changes and high level
of consistency we observe in the blood and sputum net-
work analyses are important for sex-related differences
in the disease or are a consequence of normal sex differ-
ences in cellular regulation. However, we reasoned that
the sputum networks should be “closer” to lung disease,
and thus transcription factors that are regulating bio-
logical functions in sputum but not in blood may be the
most important drivers of sex-specific and disease-specific
functional regulation. Therefore, to partially address our
lack of healthy controls, we next directly compared the
transcription-factor specific differential-targeting of func-
tions in the sputum versus the blood networks.
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targeting of the ten functions in Figure 6A by calculating,
for each transcription factor, the Spearman correlation be-
tween the significance levels in the sputum sex-specific
network comparison and the significance levels in the
blood sex-specific network comparison. A distribution of
these correlation values is shown in Figure 6B.
Most transcription factors have a high positive correl-
ation value, indicating that they are increasing/decreasing
their targeting of these biological functions between men
and women similarly in both sputum and blood networks.
Some of this sexually-dimorphic targeting may be related
to COPD, however, it is also possible, since this behavior
was observed in both sputum and blood samples, that it is
a consequence of normal sex-differences. On the other
hand, there is a relatively smaller subset of transcription
factors – those with negative correlation coefficients –
whose sexually-dimorphic targeting of these important
functions is opposite in the sputum and blood networks.
We indicate the 23 transcription factors with correlation
less than −0.4 by arrows in Figure 6A.
The transcription factors most differentially-targeting
these key functions between sputum and blood, based on
our correlation measure, include the HAND1::TCFE2A
complex, FOXF2, PAX4, the MYC::MAX complex, and
SOX5 (Figures 6C-G). Both FOXF2 and SOX5 have been
implicated in COPD or lung biology and it is interesting
that we observe them in this sex-specific context. For ex-
ample, FOXF2 has been shown to quantitatively increase
binding upon smoke exposure in female mice [58] and
modulates the expression of lung genes [59]. SOX5 is a
candidate for COPD susceptibility and important for lung
development [60].
A network model for sex-specific targeting of
functionally-related genes in COPD
The GSEA analysis we have performed based on the
differential-targeting of genes is clearly very powerful
Figure 5 Transcription-factor differential-targeting of biological functions. (A) A hierarchical clustering of the t-statistic associated with differential
edge weight between ensembles of female and male sputum networks. Each point in the matrix represents the t-statistic of an individual
edge extending from a transcription factor (column) to a gene (row) (B-C) The statistical enrichment of GO categories in genes differentially-
targeted by a transcription factor between male and female (B) sputum and (C) blood networks. All categories significantly (FDR<0.01) differentially-
targeted by at least one of the transcription factors, in the given tissue-type, is shown. The columns (transcription factors) are ordered identically to the
hierarchical clustering in (A) and we observe a strong correlation with the transcription-factor differential-targeting of GO categories in (B). Although
there is some similarity in the transcription-factor differential-targeting of these functional sets of genes in the sputum and blood networks, there is
overall less enrichment in the blood comparison.
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logical functions targeted in a sexually-dimorphic manner
in COPD as well as several transcriptional regulators that
may be mediating those differences. One strength of this
analysis is that it relies upon characterizing network differ-
ences based on relative changes in targeting patterns.
However, in doing so it also ignores the actual strength of
predicted network interactions. In other words, if a gene is
more targeted in one ensemble of networks relative to the
other, that gene is highly implicated in the GSEA analysis,
even if its input edges have low absolute edge-weight
values predicted across all the networks in both ensem-
bles. It is unlikely that the systemic differential-targeting
of functions we see across our panel of transcription fac-
tors in Figure 6A actually corresponds to multiple strong
regulatory interactions from every one of them.
Figure 6 Identifying disease-specific drivers of sexually-dimorphic functional targeting. (A) Sputum (top panel) and blood (bottom panel)
transcription-factor specific enrichment for differential-targeting of the top five GO functions identified in either males or females in Figure 4B. (B)
A distribution of the similarity between differential-targeting patterns of transcription factors in sputum and blood network, as measured using
the Spearman correlation. A red line indicates the cutoff used to identify transcription factors that have opposite sex-specific regulatory patterns
in sputum compared to blood networks. (C-G) Plots comparing individual transcription factors’ sex-specific differential-targeting of these GO functions
(five in female, filled shapes, and five in male, hollow shapes) in the sputum versus the blood networks.
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latory interactions and the results of our functional analysis,
we next visualized subnetworks based on the female-
specific and male-specific edges we previously identified
(Figures 2B-C). In order to interpret our functional results
in this regulatory network context we identified sex-specific
edges that extend between the 23 disease-specific
transcription factors and genes annotated to the top
differentially-targeted functions. We illustrate the result-
ing subnetworks in Figure 7. Edges and genes are colored
pink or blue based on whether they were identified as part
of the female or male networks or functions, respectively.
We observe that some transcription factors, such as
CREB1 and ZFX target distinct sets of genes in both the
male and female sputum networks. ZFX is the X-linked
version of a protein that plays a role in molecular sex
determination [61], so it may not be surprising that we
found sex-specific differences in its regulatory patterns.
However, it has also been implicated in lung cancer
[62,63]. Similarly CREB is over-expressed in many can-
cers, including lung cancer [64], and, interestingly, has
been shown to interact with the estrogen receptor and
to have age and sex- dependent expression patterns in
the human brain [65].
Several transcription factors dominate in one sex
compared to the other. For example, the MYC::MAX
complex appears to primarily target genes annotated to
functions enriched in the female-specific sputum net-
work (but not in the blood network) while SOX5 tar-
gets genes in the male-specific sputum network. USF1,
in particular, appears to be a “hub” transcription factor
for the female functionally related-genes in the sputum
networks.
USF1 both regulates and interacts directly with estrogen
receptor (ER) in a protein complex [66], which may ex-
plain its female-specific activity. Estrogen has also been
shown to induce USF1 to bind to the regulatory regions of
several genes [67-69]. USF1 is involved in the cross-talk
between hypoxia-related elements such as Aryl hydrocar-
bon receptor (AHR) and the estrogen receptor, inhibiting
the former [70-72]. This relationship may be important in
sex-specific COPD biology as AHR has previously been
identified as potentially important for sex-specific differ-
ences in lung cancer [73].
Sex-specific effects of USF1 have been noted previously
[74,75]. Consistent with our findings, it has been reported
that in mouse liver, male gene signatures are enriched
for functions such as immune response while female
AB
Figure 7 Illustrations of core subnetworks of sex-specific regulation in COPD. (A) The sputum subnetwork, defined by sputum sex-specific
edges (as shown in Figure 2B) that extend between the identified disease-specific drivers (Figure 6B) and genes annotated to one of the top five
differentially-targeted GO categories in ensembles of networks built based on sputum expression data (Figures 4B and 6). (B) The blood subnetwork,
defined by blood sex-specific edges (Figure 2C) that extend between the identified disease-specific drivers (Figure 6B) and genes annotated to top five
GO categories identified as differentially-targeted between male and female networks (Figures 4B and 6). Edges and genes are colored pink or blue
based on whether they were identified as part of the female or male networks or functions, respectively.
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tase activity and mitochondrion [75]. ChIP of USF1 in
HepG2 cells also indicates that it regulates nuclear mito-
chondrial genes [76]. Most interestingly, however, is that
fact that USF1 has been shown to bind to the promoter
and mediate the expression of PGC-1α [77,78] which, as
we previously noted, is an important regulator of mito-
chondrial biogenesis [57], and, along with several PPARs,
has been shown to be expressed at lower levels in the skel-
etal muscle of COPD patients [55]. Therefore, it is not un-
reasonable to suppose that USF1, as indicated by our
PANDA network analysis, may be an important mediator
of mitochondrial-activity in a sexually-dimorphic manner
in patients with COPD.
Conclusions
In this study we identified functionally related sets of
genes that are strongly differentially-targeted between
men and women with COPD. Our results suggest that
sexual dimorphism in features of COPD may be a conse-
quence of the re-wiring of cellular networks around par-
ticular biological pathways, especially those involved in
mitochondrial function and energy metabolism, leading to
differences in COPD in men and women. Although these
functions have previously been implicated in COPD, little
is known about their disease- and sex-specific regulation.
In addition, despite the fact that there is a large body of
research concerning the structural features of individual
regulatory networks [79-82], quantifying differences in
network features is relatively understudied and there
are few systematic approaches for characterizing vari-
ability in gene targeting. In our analysis we contrasted
networks and identified functionally related sets of genes
that are strongly differentially-targeted between men and
women with COPD.
One of our most striking findings was clear differential-
targeting patterns in the absence of similarly compelling
differential-expression. Several potential biological mecha-
nisms may play a role in mediating this differential target-
ing. One possibility is that multiple transcription factors
compete for the same binding site upstream of a given tar-
get gene, but which one primarily regulates that gene is
dependent on the cellular context (for example a change
in protein abundance or conformation in response to sex
hormones). Another possibility is that several transcrip-
tion factors have potential binding sites upstream of a
gene, but in females certain sites are inactive (for example
through an epigenetic factor or a mutation) and in males
others are inactive.
Using a network-based approach we were able to iden-
tify potential sex- and disease-specific transcriptional
regulators of these biological functions, the most striking
of which was USF1. Although USF1 has previously been
implicated both in the regulation of nuclear mitochon-
drial genes and in sexual-dimorphism, its specific role in
COPD is largely unknown and our findings are an im-
portant step in beginning to understand its potential im-
portance. Curiously, an increase or decrease in overall
out-degree by transcription factors between male and fe-
male networks did not always directly correspond to
differential-targeting of particular biological functions be-
tween male and female networks. For example USF1 had
an overall higher out-degree in male networks (Figure 3E),
yet it also had increased targeting of mitochondrial func-
tions in female networks (Figures 6 and 7). This highlights
the importance of interpreting network measures within a
functional context.
As with any computational analysis, there are limita-
tions in our investigation that result from the underlying
data we used; for example the number of genes included
on the expression array may affect the comprehensive-
ness of the information incorporated in the model. One
limitation in our specific application is that, although we
found many sex-specific regulatory features, the sputum
and blood expression data we used was only collected
from individuals with COPD, and thus we lacked truly
“normal” controls—this is a crucial direction for future
research. However, by focusing on sex differences we ob-
served just in the sputum networks and not the blood
networks, we believe our findings are likely to represent
sex-specific network alterations that are important for
COPD. We also used a covariate-free model to evaluate
differential-expression in order to be consistent with our
subsequent regulatory network analysis, which does not
directly model the role of covariates. It is therefore pos-
sible that in addition to the sex-specific regulatory changes
we observe, there may also be gene expression differences
between men and women with COPD that are simply not
captured using a covariate-free approach. However, we
suggest that is equally likely that similar outcomes in gene
expression are mediated by distinct sets of transcriptional
regulators. For example, it is reasonable to imagine that
sex hormones (such as estrogen), which we only modeled
in our network through receptor binding sites, might
change the functions of some transcription factors (for ex-
ample USF1) in other ways, requiring cells to respond and
differentially rewire the effected portion of their regulatory
network in order to maintain viability. In this case the
overall expression profile of the cells might be similar,
but the factors mediating that response could be vastly
different.
Genomic assays, such as gene expression data, provide a
snapshot of the state of a cell and most widely used ana-
lysis approaches identify differences in individual genes by
collectively comparing groups of samples. We believe one
limitation of gene-centered approaches, especially in the
context explored here, is due to the fact that individual
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states, but that phenotypic alterations are better character-
ized by networks of interactions linking genes. In contrast,
our network approach, although complementary to differ-
ential gene expression analysis, highlights fundamentally
different aspects of sex-specific biology. Namely, that a
gene, or a collection of genes involved in a biological func-
tion, may be similarly expressed in both men and women,
but this expression may be regulated by different up-
stream factors. Understanding how the targeting of bio-
logical functions is distinct between sexes in COPD
helped to elucidate potentially sexually-dimorphic mecha-
nisms of the disease, an endeavor with relevance for both
sex-specific diagnostics and therapeutics. Differential tar-
geting of biological pathways is likely not limited to sex-
specific disease features, and we believe the methods we
employ here will be widely applicable to better under-
standing other biological systems and diseases.
Methods
Building ensembles of PANDA networks using a jack-knife
We used PANDA [21] to integrate expression information
with transcription factor motif and protein-interaction
data. In our analysis we parsed the expression data by sex,
employed a jack-knifing procedure and ran PANDA mul-
tiple times to construct sets of sex-specific, genome-wide
transcriptional regulatory networks. The specifics of how
we processed the input data and reconstructed the
PANDA network models are included below:
Expression data
We obtained the CEL data files for 264 expression experi-
ments performed on blood and sputum samples collected
from 132 individuals and profiled using Affymetrix HGU
133 plus2 microarrays. We RMA-normalized the expres-
sion data in R [26,83], and mapped probes to Entrez-gene
IDs using a custom CDF [27]. These data include 18960
probes sets, mapping to 18895 unique genes (based on
Hugo Gene Symbols). 15820 of these genes are also in-
cluded in our motif scan (see below), including 651 on the
sex chromosomes. After an initial PCA analysis investigat-
ing the clustering of samples based on the expression of
genes on the Y chromosome, we excluded genes on the
sex chromosomes and removed expression samples for 6
individuals who did not cluster correctly according to sex.
We used expression data for the remaining 126 individuals
(42 females and 84 males) and 15169 genes when con-
structing sex- and tissue-specific genome-wide regulatory
networks. We also created a “random” version of the spu-
tum expression data by permuting autosomal gene labels.
Motif data
We obtained position weight matrixes (PWM) for 130
core vertebrate transcription factor motifs from JASPAR
[84,85]. To identify the target locations for each motif,
each candidate sequence S was given a motif score equal
to log [P(S|M)/P(S|B)], where P(S|M) is the probability
of observing sequence S given motif M, and P(S|B) is the
probability of observing sequence S given the genome
background B. We modeled the distribution of these motif
scores by randomly sampling the genome 10
6 times. Motif
sites with a significance level of p<10
−5 and that fell
within the promoter region ([−750, 250] base-pairs around
the transcriptional start site) of one of the genes measured
on our expression arrays were used to defined as an edge
between a motif and that gene in our regulatory network
prior.
It is important to note that although when building our
primary network models we did not include genes on the
sex chromosome as potential targets, we did not remove
motif information for sites bound by transcription factors
encoded on the sex chromosomes (such as AR on chrX
and SRY on chrY). We reasoned that since the motif se-
quences for these transcription factors still exist in the
regulatory regions of autosomal genes they can still be in-
dicative of information about a target gene’s local regula-
tory network structure.
PPI data
Interactions between human transcription factors were
obtained from the supplemental material of [34]. We ex-
cluded interactions in this set when either transcription
factor in the interaction did not directly match one of
the motifs included in our regulatory network prior.
Reconstructing PANDA networks
To construct multiple sex- and tissue- specific network
models, we selected ten subjects of the same sex at ran-
dom, identified the sputum, blood and “random” expres-
sion data associated with these subjects, and used PANDA
to, separately, integrate each of these three sample-sets of
expression data with motif and protein-protein interaction
data. We did multiple random selections of subjects of the
same sex, constructing one hundred female-specific and
one hundred male-specific networks for each tissue.
Identifying differentially-called edges between network
ensembles
PANDA reports the probability that an edge exists be-
tween a transcription factor (i) and gene (j) in an esti-
mated network (n) as a Z-score (Zij
(n)). To select edges
that are differentially-called between male and female net-
work ensembles, for each edge we calculated (1) its aver-
age edge-score across all networks in each of the two
ensembles, (2) the difference between these average scores,
and (3) used a t-test to evaluate the significance of the dif-
ference in edge-score distribution between the male and
female network ensembles. We corrected this significance
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tween female and male network ensembles, we then se-
lected edges that had an average edge score greater than
zero in at least one of the ensembles, an absolute edge
score difference of at least 0.25, and an FDR significance
less than 10
−5.
Clustering network differences
In order to better appreciate large scale patterns in male/
female sputum regulatory network differences, we per-
formed a hierarchical clustering on a transcription factor
by gene matrix populated with the t-statistic value of the
corresponding network edge, calculated when comparing
the distribution of predicted edge scores across the male
versus female sputum network ensembles. Hierarchical
clustering was done separately in each dimension using
one minus the Pearson correlation as the distance metric
and the “complete” linkage method.
GSEA
To run GSEA in a consistent manner on both gene ex-
pression and network regulatory data, we downloaded the
java command line version of the program from www.
broadinstitute.org/gsea/. We ran GSEA permuting gene
set labels. Further, in order to ensure consistency between
the GSEA analysis and the functional enrichment ana-
lysis we performed using Fisher’se x a c tt e s t( s h o w ni n
Figure 2H-J), we ran the GSEA program using custom
Gene Matrix Transposed (GMT) files that we constructed
from human GO annotations downloaded from geneon-
tology.org (access date: 02/02/13).
In analyzing the GSEA results, we consider the FDR
p-values reported by GSEA. Specifically, we report enrich-
ment in female categories based on the –log10(FDR) sig-
nificance (resulting in positive values), and enrichment in
male categories based on the+log10(FDR) significance
(resulting in negative values).
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